# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Srinivasa Ramanujan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET020-SYN
- Date: 2026-02-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Edmund Ashworth, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six weeks: recovery, final sputum cultures, liver tests before rifampin, vitamin B12, mood, influenza vaccine. **S**

## History of present illness

Mr. Ramanujan returns six weeks after diagnosis. He finished paromomycin as planned and his stools returned to normal within two days. He has had no fever, the pain under his ribs has gone, and he has gained almost 3 kg. He is cooking twice a day now, with milk and curd daily, and takes his vitamin B12 and weekly vitamin D. He sees the counselor weekly, calls his family each Sunday, and has been to two community meals with families from the local Tamil association. The final sputum cultures from January show no growth at six weeks; Dr. Raghunathan reviewed them and the plan for latent infection by message. He is working full days again. **S**

| Element | Detail |
|---|---|
| Abscess treatment | Metronidazole and paromomycin completed |
| Sputum cultures | No growth at six weeks |
| Weight | Up nearly 3 kg |
| Mood | PHQ-9 8 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or sweats; appetite good |
| Gastrointestinal | Negative | No abdominal pain; stools normal |
| Respiratory | Negative | No cough |
| Neurological | Negative | No numbness or tingling |
| Psychiatric | Positive | Mood better; still misses his family; no thoughts of self-harm |

5 systems reviewed. **S**

## Current medications

- Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily **S**
- Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks **S**
- Rifampin 300 mg oral capsule, two capsules (600 mg) once daily on an empty stomach for 4 months **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 54.8 kg; BMI 20.1 kg/m². All vital signs are synthetic.

White blood cells: 6.8 10*3/uL; Hemoglobin: 12.6 g/dL (low); Mean cell volume: 94 fL; Platelets: 290 10*3/uL; C-reactive protein: 6 mg/L (high); Alkaline phosphatase: 118 U/L; ALT: 28 U/L; AST: 24 U/L; Bilirubin, total: 0.6 mg/dL; Albumin: 3.9 g/dL; Vitamin B12: 410 pg/mL; PHQ-9: 8; GAD-7: 6. All results are synthetic.

## Change since baseline

- White blood cells: 13.6 10*3/uL (high) at baseline, 6.8 10*3/uL at this visit **S**
- Hemoglobin: 11.2 g/dL (low) at baseline, 12.6 g/dL (low) at this visit **S**
- Mean cell volume: 99 fL at baseline, 94 fL at this visit **S**
- Platelets: 412 10*3/uL (high) at baseline, 290 10*3/uL at this visit **S**
- C-reactive protein: 92 mg/L (high) at baseline, 6 mg/L (high) at this visit **S**
- Alkaline phosphatase: 214 U/L (high) at baseline, 118 U/L at this visit **S**
- ALT: 46 U/L (high) at baseline, 28 U/L at this visit **S**
- AST: 38 U/L at baseline, 24 U/L at this visit **S**
- Bilirubin, total: 0.9 mg/dL at baseline, 0.6 mg/dL at this visit **S**
- Albumin: 3.2 g/dL (low) at baseline, 3.9 g/dL at this visit **S**
- Vitamin B12: 168 pg/mL (low) at baseline, 410 pg/mL at this visit **S**
- PHQ-9: 12 at baseline, 8 at this visit **S**
- GAD-7: 9 at baseline, 6 at this visit **S**

## Immunizations given today

- Influenza vaccine, inactivated, this season **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; temperature 36.6 °C, pulse 74; weight 54.8 kg |
| Respiratory | Clear, including the right base |
| Abdomen | Liver not enlarged or tender |
| Skin | No jaundice |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Amebic liver abscess** (A06.4). Clinically resolved after metronidazole and paromomycin: CRP 6 mg/L; alkaline phosphatase 118, ALT 28, AST 24 U/L, bilirubin 0.6 mg/dL, albumin 3.9 g/dL. **S**
   - No repeat imaging while he stays well.
   - Three-month review.
2. **Latent tuberculosis infection** (Z22.7). Cultures negative at six weeks with negative smears, NAAT and radiograph: active tuberculosis excluded. The positive IGRA is latent infection, worth treating at his age and after recent illness. With normal liver tests and the abscess treated, rifampin for four months is the preferred, shortest daily regimen; it does not interact with his vitamins, though it speeds vitamin D breakdown. **S**
   - Rifampin 600 mg each morning before breakfast for 4 months.
   - Orange urine, sweat and tears are expected; stop and call for jaundice, rash, or vomiting.
   - Monthly clinical checks and liver tests at two months.
3. **Vitamin B12 deficiency with anemia** (D51.3). Hemoglobin 12.6 g/dL from 11.2, MCV 94 fL; B12 410 pg/mL. Responding. **S**
   - Continue B12 daily, long term.
4. **Adjustment disorder with depressed mood** (F43.21). PHQ-9 8 and GAD-7 6. Safety reviewed: no thoughts of suicide or self-harm; safety plan current. **S**
   - Continue weekly counseling and weekly calls home.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Temperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness) | Every visit | Completed today | Afebrile; liver not tender |
| Examination | Weight and BMI | Every visit | Completed today | 54.8 kg, up 2.8 kg since intake |
| Laboratory | Blood count and C-reactive protein | At diagnosis, at the end of the tissue course, then until normal | Completed today | White cells 6.8, hemoglobin 12.6, MCV 94, platelets 290; CRP 6 mg/L |
| Laboratory | Liver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin) | At diagnosis, at the end of therapy, and before and during rifampin | Completed today | Normal, the baseline before rifampin |
| Laboratory | Sputum acid-fast smears, NAAT and mycobacterial cultures | Three samples at baseline; cultures final at 6 to 8 weeks | Completed today | Cultures no growth at six weeks; active tuberculosis excluded |
| Medication safety | Amebicide safety and completion (nausea, metallic taste, numbness on metronidazole; diarrhea on paromomycin; no overlap) | At the start and every visit during treatment | Completed today | Both courses completed without lasting side effects |
| Medication safety | Rifampin safety and adherence (nausea, rash, jaundice, missed doses, drug interactions) | Monthly clinical check; liver tests at baseline and as indicated | Completed today | Started today; interactions reviewed; side effects explained |
| Laboratory | Response to vitamin B12 replacement | Reticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosis | Completed today | Hemoglobin 12.6 g/dL and B12 410 pg/mL; blood count again at three months |
| Self-management | Diet and weight plan within his vegetarian rules | Every visit | Completed today | Two meals a day; milk and curd daily |
| Survey | PHQ-9 and GAD-7 | At least monthly while symptoms are active | Completed today | PHQ-9 8, GAD-7 6 |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
| Self-management | Support far from home (counseling, contact with family and community, department and fellowship) | Every visit | Completed today | Weekly counseling, calls home and community meals |
| Medication safety | Influenza vaccine | Each season | Completed today | Given today; deferred at intake because of fever |
| Referral | Infectious diseases review | At diagnosis; then at six weeks for the cultures and latent infection | Completed today | Dr. Raghunathan reviewed the cultures and agreed with rifampin by message |

## Goal progress

- A diagnosis within days, with tuberculosis either confirmed or excluded before any treatment that could hide it. Outcome by 2026-02-23: Amebic liver abscess diagnosed at the second visit; active tuberculosis excluded by the radiograph, three smears, NAAT and cultures at six weeks. **S**
- No fever, the abscess treated, and the luminal course completed. In progress; target 2026-04-20. **S**
- Regain at least half of the lost weight within three months, on a diet that keeps his rules. In progress; target 2026-04-20. **S**
- Vitamin B12 and vitamin D in the normal range and the anemia resolved. In progress; target 2026-04-20. **S**
- PHQ-9 below 10 with no thoughts of self-harm, and regular contact with people who matter to him. In progress; target 2026-04-20. **S**
- Complete four months of rifampin for latent tuberculosis infection. In progress; target 2026-04-20. **S**

## Medication changes

- Started: Rifampin 300 mg oral capsule, two capsules (600 mg) once daily on an empty stomach for 4 months **S**

## Guideline basis

- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017), ATS, IDSA and CDC (Clin Infect Dis 2017)
- Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020), Centers for Disease Control and Prevention (MMWR Recomm Rep 2020)
- DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026), Centers for Disease Control and Prevention
- A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018), Shirley DT et al., Open Forum Infect Dis 2018
- Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016), Academy of Nutrition and Dietetics (J Acad Nutr Diet 2016)
- CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026), Aether Forge
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Monthly clinical check on rifampin; preventive visit in about six weeks. Three-month review with blood count, liver tests, vitamins and mood. Call for jaundice, rash, vomiting, or fever. **S**
- Next scheduled visit 2026-04-06: periodic adult preventive visit with pre-travel advice. **S**
